Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for MECP2
Z-value: 1.83
Motif logo
Transcription factors associated with MECP2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MECP2
|
ENSG00000169057.15 | methyl-CpG binding protein 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MECP2 | hg19_v2_chrX_-_153363125_153363182 | 0.24 | 2.1e-01 | Click! |
Activity profile of MECP2 motif
Sorted Z-values of MECP2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr18_+_33877654 | 7.12 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr19_-_51471362 | 7.12 |
ENST00000376853.4
ENST00000424910.2 |
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51471381 | 6.84 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr13_-_20806440 | 5.77 |
ENST00000400066.3
ENST00000400065.3 ENST00000356192.6 |
GJB6
|
gap junction protein, beta 6, 30kDa |
| chr19_-_51472222 | 5.64 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
| chr1_-_17307173 | 5.48 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
| chr19_-_51472031 | 5.26 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr17_+_70117153 | 5.16 |
ENST00000245479.2
|
SOX9
|
SRY (sex determining region Y)-box 9 |
| chr21_-_44496441 | 5.10 |
ENST00000359624.3
ENST00000352178.5 |
CBS
|
cystathionine-beta-synthase |
| chr1_+_150522222 | 4.89 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
| chr2_+_23608064 | 4.68 |
ENST00000486442.1
|
KLHL29
|
kelch-like family member 29 |
| chr1_-_6545502 | 4.55 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr20_-_56284816 | 4.52 |
ENST00000395819.3
ENST00000341744.3 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
| chr9_+_131182697 | 4.26 |
ENST00000372838.4
ENST00000411852.1 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
| chr2_-_224903995 | 4.18 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
| chr2_-_235405679 | 4.05 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr10_+_28966271 | 4.04 |
ENST00000375533.3
|
BAMBI
|
BMP and activin membrane-bound inhibitor |
| chr12_-_47473642 | 4.02 |
ENST00000266581.4
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr18_-_28681950 | 4.01 |
ENST00000251081.6
|
DSC2
|
desmocollin 2 |
| chr2_-_31360887 | 3.98 |
ENST00000420311.2
ENST00000356174.3 ENST00000324589.5 |
GALNT14
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
| chr8_+_86376081 | 3.86 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
| chr17_+_74381343 | 3.85 |
ENST00000392496.3
|
SPHK1
|
sphingosine kinase 1 |
| chr20_-_43280361 | 3.56 |
ENST00000372874.4
|
ADA
|
adenosine deaminase |
| chr22_+_51112800 | 3.52 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
| chr12_-_51785182 | 3.50 |
ENST00000356317.3
ENST00000603188.1 ENST00000604847.1 ENST00000604506.1 |
GALNT6
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
| chr2_+_70142232 | 3.46 |
ENST00000540449.1
|
MXD1
|
MAX dimerization protein 1 |
| chr4_-_57522470 | 3.41 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
| chr12_-_47473707 | 3.39 |
ENST00000429635.1
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr4_-_57522598 | 3.36 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
| chr1_-_20812690 | 3.36 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr20_-_43280325 | 3.36 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
| chr2_+_95691417 | 3.36 |
ENST00000309988.4
|
MAL
|
mal, T-cell differentiation protein |
| chr13_-_60738003 | 3.32 |
ENST00000400330.1
ENST00000400324.4 |
DIAPH3
|
diaphanous-related formin 3 |
| chr12_-_76425368 | 3.27 |
ENST00000602540.1
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1 |
| chr6_-_4135693 | 3.25 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr17_+_74380683 | 3.22 |
ENST00000592299.1
ENST00000590959.1 ENST00000323374.4 |
SPHK1
|
sphingosine kinase 1 |
| chr4_+_4388805 | 3.21 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
| chr5_-_77944648 | 3.21 |
ENST00000380345.2
|
LHFPL2
|
lipoma HMGIC fusion partner-like 2 |
| chr22_-_37915535 | 3.17 |
ENST00000403299.1
|
CARD10
|
caspase recruitment domain family, member 10 |
| chr2_+_95691445 | 3.04 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
| chr12_-_47473425 | 3.02 |
ENST00000550413.1
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr12_-_47473557 | 2.99 |
ENST00000321382.3
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr16_-_85784718 | 2.96 |
ENST00000602766.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
| chr6_-_4135825 | 2.95 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr15_-_91537723 | 2.95 |
ENST00000394249.3
ENST00000559811.1 ENST00000442656.2 ENST00000557905.1 ENST00000361919.3 |
PRC1
|
protein regulator of cytokinesis 1 |
| chr4_-_57522673 | 2.94 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
| chr20_+_361890 | 2.94 |
ENST00000449710.1
ENST00000422053.2 |
TRIB3
|
tribbles pseudokinase 3 |
| chr11_-_2160611 | 2.91 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr5_-_72744336 | 2.89 |
ENST00000499003.3
|
FOXD1
|
forkhead box D1 |
| chr21_-_16437126 | 2.87 |
ENST00000318948.4
|
NRIP1
|
nuclear receptor interacting protein 1 |
| chr8_+_22022800 | 2.79 |
ENST00000397814.3
|
BMP1
|
bone morphogenetic protein 1 |
| chr19_-_1513188 | 2.79 |
ENST00000330475.4
|
ADAMTSL5
|
ADAMTS-like 5 |
| chr17_-_80009650 | 2.76 |
ENST00000310496.4
|
RFNG
|
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| chr6_-_2903514 | 2.75 |
ENST00000380698.4
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
| chr6_+_86159821 | 2.74 |
ENST00000369651.3
|
NT5E
|
5'-nucleotidase, ecto (CD73) |
| chr14_+_100070869 | 2.67 |
ENST00000502101.2
|
RP11-543C4.1
|
RP11-543C4.1 |
| chr7_+_48128816 | 2.67 |
ENST00000395564.4
|
UPP1
|
uridine phosphorylase 1 |
| chr15_+_69706643 | 2.65 |
ENST00000352331.4
ENST00000260363.4 |
KIF23
|
kinesin family member 23 |
| chr10_-_17659234 | 2.64 |
ENST00000466335.1
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
| chr15_-_83953466 | 2.63 |
ENST00000345382.2
|
BNC1
|
basonuclin 1 |
| chr19_+_2096868 | 2.61 |
ENST00000395296.1
ENST00000395301.3 |
IZUMO4
|
IZUMO family member 4 |
| chr19_-_51472823 | 2.60 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr21_-_44495964 | 2.60 |
ENST00000398168.1
ENST00000398165.3 |
CBS
|
cystathionine-beta-synthase |
| chr20_+_6748311 | 2.58 |
ENST00000378827.4
|
BMP2
|
bone morphogenetic protein 2 |
| chr20_+_62694834 | 2.57 |
ENST00000415602.1
|
TCEA2
|
transcription elongation factor A (SII), 2 |
| chr12_-_54813229 | 2.56 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
| chr16_-_85784634 | 2.56 |
ENST00000284245.4
ENST00000602914.1 |
C16orf74
|
chromosome 16 open reading frame 74 |
| chr12_-_124018252 | 2.55 |
ENST00000376874.4
|
RILPL1
|
Rab interacting lysosomal protein-like 1 |
| chr21_-_16437255 | 2.55 |
ENST00000400199.1
ENST00000400202.1 |
NRIP1
|
nuclear receptor interacting protein 1 |
| chr11_-_65667997 | 2.54 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
| chr4_-_103266355 | 2.52 |
ENST00000424970.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
| chr4_-_80994471 | 2.52 |
ENST00000295465.4
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr19_+_8429031 | 2.51 |
ENST00000301455.2
ENST00000541807.1 ENST00000393962.2 |
ANGPTL4
|
angiopoietin-like 4 |
| chr3_-_52090461 | 2.51 |
ENST00000296483.6
ENST00000495880.1 |
DUSP7
|
dual specificity phosphatase 7 |
| chr11_+_849816 | 2.50 |
ENST00000527644.1
|
TSPAN4
|
tetraspanin 4 |
| chr6_-_131384412 | 2.50 |
ENST00000445890.2
ENST00000368128.2 ENST00000337057.3 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
| chr7_-_27135591 | 2.49 |
ENST00000343060.4
ENST00000355633.5 |
HOXA1
|
homeobox A1 |
| chr9_+_139560197 | 2.48 |
ENST00000371698.3
|
EGFL7
|
EGF-like-domain, multiple 7 |
| chr16_+_66638685 | 2.45 |
ENST00000565003.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr3_-_52567792 | 2.44 |
ENST00000307092.4
ENST00000422318.2 ENST00000459839.1 |
NT5DC2
|
5'-nucleotidase domain containing 2 |
| chr7_+_40174565 | 2.39 |
ENST00000309930.5
ENST00000401647.2 ENST00000335693.4 ENST00000413931.1 ENST00000416370.1 ENST00000540834.1 |
C7orf10
|
succinylCoA:glutarate-CoA transferase |
| chr19_+_531713 | 2.39 |
ENST00000215574.4
|
CDC34
|
cell division cycle 34 |
| chr13_-_20767037 | 2.39 |
ENST00000382848.4
|
GJB2
|
gap junction protein, beta 2, 26kDa |
| chr7_-_98741714 | 2.38 |
ENST00000361125.1
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1 |
| chr2_+_64681103 | 2.37 |
ENST00000464281.1
|
LGALSL
|
lectin, galactoside-binding-like |
| chr19_+_35645618 | 2.36 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr8_-_124428569 | 2.36 |
ENST00000521903.1
|
ATAD2
|
ATPase family, AAA domain containing 2 |
| chr14_-_75422280 | 2.35 |
ENST00000238607.6
ENST00000553716.1 |
PGF
|
placental growth factor |
| chr6_+_86159765 | 2.34 |
ENST00000369646.3
ENST00000257770.3 |
NT5E
|
5'-nucleotidase, ecto (CD73) |
| chr6_+_31371337 | 2.34 |
ENST00000449934.2
ENST00000421350.1 |
MICA
|
MHC class I polypeptide-related sequence A |
| chr1_-_17304771 | 2.34 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
| chr19_+_532049 | 2.33 |
ENST00000606136.1
|
CDC34
|
cell division cycle 34 |
| chr19_+_39903185 | 2.32 |
ENST00000409794.3
|
PLEKHG2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
| chr19_+_45281118 | 2.32 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr16_-_420338 | 2.31 |
ENST00000450882.1
ENST00000441883.1 ENST00000447696.1 ENST00000389675.2 |
MRPL28
|
mitochondrial ribosomal protein L28 |
| chr5_-_1524015 | 2.30 |
ENST00000283415.3
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1 |
| chr2_-_72375167 | 2.30 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
| chr13_-_60737898 | 2.28 |
ENST00000377908.2
ENST00000400319.1 ENST00000400320.1 ENST00000267215.4 |
DIAPH3
|
diaphanous-related formin 3 |
| chr9_-_123639304 | 2.25 |
ENST00000436309.1
|
PHF19
|
PHD finger protein 19 |
| chr11_+_69924639 | 2.21 |
ENST00000538023.1
ENST00000398543.2 |
ANO1
|
anoctamin 1, calcium activated chloride channel |
| chr10_+_94833642 | 2.21 |
ENST00000224356.4
ENST00000394139.1 |
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1 |
| chr19_-_19051927 | 2.18 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
| chr2_-_10220538 | 2.17 |
ENST00000381813.4
|
CYS1
|
cystin 1 |
| chr19_+_1407733 | 2.16 |
ENST00000592453.1
|
DAZAP1
|
DAZ associated protein 1 |
| chr14_-_91720224 | 2.16 |
ENST00000238699.3
ENST00000531499.2 |
GPR68
|
G protein-coupled receptor 68 |
| chr10_+_50822480 | 2.16 |
ENST00000455728.2
|
CHAT
|
choline O-acetyltransferase |
| chr8_-_10588010 | 2.16 |
ENST00000304501.1
|
SOX7
|
SRY (sex determining region Y)-box 7 |
| chr1_-_204121013 | 2.15 |
ENST00000367201.3
|
ETNK2
|
ethanolamine kinase 2 |
| chr12_-_2986107 | 2.15 |
ENST00000359843.3
ENST00000342628.2 ENST00000361953.3 |
FOXM1
|
forkhead box M1 |
| chr11_+_842928 | 2.14 |
ENST00000397408.1
|
TSPAN4
|
tetraspanin 4 |
| chr7_-_98741642 | 2.12 |
ENST00000361368.2
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1 |
| chr8_+_145202939 | 2.12 |
ENST00000423230.2
ENST00000398656.4 |
MROH1
|
maestro heat-like repeat family member 1 |
| chr19_+_10216899 | 2.11 |
ENST00000428358.1
ENST00000393796.4 ENST00000253107.7 ENST00000556468.1 ENST00000393793.1 |
PPAN-P2RY11
PPAN
|
PPAN-P2RY11 readthrough peter pan homolog (Drosophila) |
| chr11_+_119076745 | 2.10 |
ENST00000264033.4
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase |
| chr9_+_128509663 | 2.10 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr21_-_44846999 | 2.08 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
| chr11_+_450255 | 2.08 |
ENST00000308020.5
|
PTDSS2
|
phosphatidylserine synthase 2 |
| chr9_-_136344197 | 2.07 |
ENST00000414172.1
ENST00000371897.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
| chr7_+_102715573 | 2.06 |
ENST00000434153.1
|
ARMC10
|
armadillo repeat containing 10 |
| chr15_+_81071684 | 2.06 |
ENST00000220244.3
ENST00000394685.3 ENST00000356249.5 |
KIAA1199
|
KIAA1199 |
| chr20_-_60942361 | 2.05 |
ENST00000252999.3
|
LAMA5
|
laminin, alpha 5 |
| chr2_-_235405168 | 2.05 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr16_-_87903079 | 2.04 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
| chr1_-_6321035 | 2.04 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
| chr7_-_24797032 | 2.03 |
ENST00000409970.1
ENST00000409775.3 |
DFNA5
|
deafness, autosomal dominant 5 |
| chr9_-_123639445 | 2.03 |
ENST00000312189.6
|
PHF19
|
PHD finger protein 19 |
| chr16_-_90085824 | 2.01 |
ENST00000002501.6
|
DBNDD1
|
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
| chr19_+_16187816 | 2.00 |
ENST00000588410.1
|
TPM4
|
tropomyosin 4 |
| chr16_-_84651647 | 2.00 |
ENST00000564057.1
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
| chr17_+_65374075 | 1.99 |
ENST00000581322.1
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
| chr8_-_10697281 | 1.98 |
ENST00000524114.1
ENST00000553390.1 ENST00000554914.1 |
PINX1
SOX7
SOX7
|
PIN2/TERF1 interacting, telomerase inhibitor 1 SRY (sex determining region Y)-box 7 Transcription factor SOX-7; Uncharacterized protein; cDNA FLJ58508, highly similar to Transcription factor SOX-7 |
| chr19_+_10381769 | 1.98 |
ENST00000423829.2
ENST00000588645.1 |
ICAM1
|
intercellular adhesion molecule 1 |
| chr17_+_6544328 | 1.98 |
ENST00000570330.1
|
TXNDC17
|
thioredoxin domain containing 17 |
| chr16_+_66638567 | 1.98 |
ENST00000567572.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr15_+_69706585 | 1.98 |
ENST00000559279.1
ENST00000395392.2 |
KIF23
|
kinesin family member 23 |
| chr17_-_27278445 | 1.97 |
ENST00000268756.3
ENST00000584685.1 |
PHF12
|
PHD finger protein 12 |
| chr17_-_43209862 | 1.97 |
ENST00000322765.5
|
PLCD3
|
phospholipase C, delta 3 |
| chr19_-_15343191 | 1.97 |
ENST00000221730.3
|
EPHX3
|
epoxide hydrolase 3 |
| chr11_-_65667884 | 1.97 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
| chr12_+_27485889 | 1.97 |
ENST00000311001.5
ENST00000261178.5 ENST00000266503.5 |
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2 |
| chr20_+_25176318 | 1.97 |
ENST00000354989.5
ENST00000360031.2 ENST00000376652.4 ENST00000439162.1 ENST00000433417.1 ENST00000417467.1 ENST00000433259.2 ENST00000427553.1 ENST00000435520.1 ENST00000418890.1 |
ENTPD6
|
ectonucleoside triphosphate diphosphohydrolase 6 (putative) |
| chr9_+_116638562 | 1.95 |
ENST00000374126.5
ENST00000288466.7 |
ZNF618
|
zinc finger protein 618 |
| chr19_-_19051993 | 1.95 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr4_+_75310851 | 1.95 |
ENST00000395748.3
ENST00000264487.2 |
AREG
|
amphiregulin |
| chr22_-_26986045 | 1.95 |
ENST00000442495.1
ENST00000440953.1 ENST00000450022.1 ENST00000338754.4 |
TPST2
|
tyrosylprotein sulfotransferase 2 |
| chr11_+_46402744 | 1.94 |
ENST00000533952.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr2_-_46385 | 1.94 |
ENST00000327669.4
|
FAM110C
|
family with sequence similarity 110, member C |
| chr18_-_21242774 | 1.94 |
ENST00000322980.9
|
ANKRD29
|
ankyrin repeat domain 29 |
| chr10_+_11865347 | 1.94 |
ENST00000277570.5
|
PROSER2
|
proline and serine-rich protein 2 |
| chr11_-_2160180 | 1.94 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr7_+_99156011 | 1.93 |
ENST00000320583.5
ENST00000357864.2 |
ZNF655
|
zinc finger protein 655 |
| chr1_-_231175964 | 1.93 |
ENST00000366654.4
|
FAM89A
|
family with sequence similarity 89, member A |
| chr21_-_44495919 | 1.92 |
ENST00000398158.1
|
CBS
|
cystathionine-beta-synthase |
| chr16_+_2479390 | 1.92 |
ENST00000397066.4
|
CCNF
|
cyclin F |
| chr9_+_132815985 | 1.91 |
ENST00000372410.3
|
GPR107
|
G protein-coupled receptor 107 |
| chr12_+_53491220 | 1.91 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
| chr16_+_66638616 | 1.90 |
ENST00000564060.1
ENST00000565922.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr11_-_125366089 | 1.90 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
| chr15_+_39873268 | 1.89 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
| chr9_-_136344237 | 1.88 |
ENST00000432868.1
ENST00000371899.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
| chr7_+_48128854 | 1.87 |
ENST00000436673.1
ENST00000429491.2 |
UPP1
|
uridine phosphorylase 1 |
| chr7_-_50861129 | 1.87 |
ENST00000439044.1
ENST00000402497.1 ENST00000335866.3 |
GRB10
|
growth factor receptor-bound protein 10 |
| chr4_+_75311019 | 1.86 |
ENST00000502307.1
|
AREG
|
amphiregulin |
| chr7_-_148580563 | 1.86 |
ENST00000476773.1
|
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
| chr4_+_1723197 | 1.86 |
ENST00000485989.2
ENST00000313288.4 |
TACC3
|
transforming, acidic coiled-coil containing protein 3 |
| chr17_+_6544356 | 1.86 |
ENST00000574838.1
|
TXNDC17
|
thioredoxin domain containing 17 |
| chr1_+_165796753 | 1.85 |
ENST00000367879.4
|
UCK2
|
uridine-cytidine kinase 2 |
| chr8_+_22022653 | 1.85 |
ENST00000354870.5
ENST00000397816.3 ENST00000306349.8 |
BMP1
|
bone morphogenetic protein 1 |
| chr19_-_49015050 | 1.84 |
ENST00000600059.1
|
LMTK3
|
lemur tyrosine kinase 3 |
| chr11_+_43964055 | 1.84 |
ENST00000528572.1
|
C11orf96
|
chromosome 11 open reading frame 96 |
| chr1_+_25071848 | 1.84 |
ENST00000374379.4
|
CLIC4
|
chloride intracellular channel 4 |
| chr12_+_27485785 | 1.84 |
ENST00000544915.1
|
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2 |
| chr6_+_20403997 | 1.84 |
ENST00000535432.1
|
E2F3
|
E2F transcription factor 3 |
| chr13_+_110959598 | 1.83 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
| chr19_-_47249679 | 1.82 |
ENST00000263280.6
|
STRN4
|
striatin, calmodulin binding protein 4 |
| chr5_-_60140089 | 1.82 |
ENST00000507047.1
ENST00000438340.1 ENST00000425382.1 ENST00000508821.1 |
ELOVL7
|
ELOVL fatty acid elongase 7 |
| chr7_+_100797726 | 1.82 |
ENST00000429457.1
|
AP1S1
|
adaptor-related protein complex 1, sigma 1 subunit |
| chr2_+_33172221 | 1.82 |
ENST00000354476.3
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr9_-_19127474 | 1.82 |
ENST00000380465.3
ENST00000380464.3 ENST00000411567.1 ENST00000276914.2 |
PLIN2
|
perilipin 2 |
| chr10_+_124221036 | 1.81 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
| chr5_-_60140009 | 1.81 |
ENST00000505959.1
|
ELOVL7
|
ELOVL fatty acid elongase 7 |
| chr15_+_90744533 | 1.81 |
ENST00000411539.2
|
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
| chr17_+_62223320 | 1.81 |
ENST00000580828.1
ENST00000582965.1 |
SNORA76
|
small nucleolar RNA, H/ACA box 76 |
| chr7_-_50860565 | 1.80 |
ENST00000403097.1
|
GRB10
|
growth factor receptor-bound protein 10 |
| chr12_-_122238464 | 1.80 |
ENST00000546227.1
|
RHOF
|
ras homolog family member F (in filopodia) |
| chr4_-_80993717 | 1.79 |
ENST00000307333.7
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr10_-_103347883 | 1.79 |
ENST00000339310.3
ENST00000370158.3 ENST00000299206.4 ENST00000456836.2 ENST00000413344.1 ENST00000429502.1 ENST00000430045.1 ENST00000370172.1 ENST00000436284.2 ENST00000370162.3 |
POLL
|
polymerase (DNA directed), lambda |
| chr9_+_137218362 | 1.79 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
| chr7_+_150811705 | 1.79 |
ENST00000335367.3
|
AGAP3
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
| chr11_-_71159380 | 1.78 |
ENST00000525346.1
ENST00000531364.1 ENST00000529990.1 ENST00000527316.1 ENST00000407721.2 |
DHCR7
|
7-dehydrocholesterol reductase |
| chr11_+_842808 | 1.78 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
| chr12_+_22778291 | 1.78 |
ENST00000545979.1
|
ETNK1
|
ethanolamine kinase 1 |
| chr2_+_102314161 | 1.78 |
ENST00000425019.1
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
| chr16_-_420514 | 1.77 |
ENST00000199706.8
|
MRPL28
|
mitochondrial ribosomal protein L28 |
| chr11_+_46403303 | 1.76 |
ENST00000407067.1
ENST00000395565.1 |
MDK
|
midkine (neurite growth-promoting factor 2) |
| chr6_-_131384373 | 1.76 |
ENST00000392427.3
ENST00000525271.1 ENST00000527411.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
| chr19_-_15343773 | 1.76 |
ENST00000435261.1
ENST00000594042.1 |
EPHX3
|
epoxide hydrolase 3 |
| chr20_+_42295745 | 1.76 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
| chr12_-_28123206 | 1.75 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr12_-_57634475 | 1.75 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of MECP2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 9.6 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 2.4 | 7.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 2.2 | 6.7 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 1.9 | 1.9 | GO:0043491 | protein kinase B signaling(GO:0043491) |
| 1.7 | 6.9 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 1.7 | 5.2 | GO:0060516 | primary prostatic bud elongation(GO:0060516) |
| 1.7 | 5.0 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.6 | 4.7 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 1.4 | 5.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 1.4 | 5.4 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 1.3 | 29.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.3 | 7.9 | GO:0030421 | defecation(GO:0030421) |
| 1.2 | 1.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.2 | 1.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 1.1 | 4.4 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.1 | 3.3 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 1.1 | 3.3 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 1.1 | 5.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 1.0 | 1.0 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.9 | 3.7 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.9 | 2.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.9 | 5.4 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.9 | 6.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.9 | 1.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.9 | 2.6 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.9 | 5.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.9 | 4.3 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.8 | 6.6 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.8 | 2.4 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.8 | 2.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.8 | 7.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.8 | 2.4 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.8 | 2.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.8 | 3.1 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.8 | 3.1 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.8 | 0.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.8 | 0.8 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.8 | 3.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.8 | 1.5 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.7 | 3.7 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.7 | 1.4 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
| 0.7 | 2.1 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 0.7 | 1.4 | GO:0048512 | rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
| 0.7 | 7.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.7 | 2.1 | GO:0051300 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.7 | 2.1 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.7 | 2.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.7 | 2.0 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.7 | 0.7 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.7 | 2.0 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.7 | 3.3 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.7 | 2.0 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.7 | 5.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.6 | 1.9 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.6 | 1.9 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.6 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.6 | 1.9 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.6 | 5.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.6 | 1.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.6 | 5.4 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.6 | 1.2 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.6 | 0.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.6 | 0.6 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.6 | 0.6 | GO:0072102 | glomerulus morphogenesis(GO:0072102) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.6 | 1.7 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.6 | 2.9 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.6 | 6.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.6 | 2.9 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
| 0.6 | 1.7 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.6 | 3.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.6 | 1.7 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.6 | 2.3 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.6 | 2.8 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 0.6 | 4.5 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.6 | 2.2 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.6 | 1.7 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.5 | 8.2 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.5 | 3.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.5 | 1.1 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.5 | 2.1 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.5 | 1.6 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.5 | 1.1 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.5 | 1.6 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.5 | 4.2 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.5 | 1.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 | 1.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.5 | 3.1 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.5 | 2.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.5 | 2.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.5 | 6.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.5 | 3.1 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.5 | 1.5 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 0.5 | 1.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.5 | 2.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.5 | 0.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.5 | 3.0 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.5 | 5.5 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.5 | 3.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.5 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.5 | 0.5 | GO:0006826 | iron ion transport(GO:0006826) |
| 0.5 | 1.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.5 | 1.5 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.5 | 1.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.5 | 1.9 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.5 | 7.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.5 | 1.5 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.5 | 1.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.5 | 1.4 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.5 | 2.4 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.5 | 2.4 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.5 | 7.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 | 7.5 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.5 | 1.4 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.5 | 1.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 | 1.8 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.5 | 3.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.5 | 1.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.5 | 7.4 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.5 | 1.4 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.5 | 0.5 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.5 | 0.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.5 | 1.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.5 | 1.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.5 | 1.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.5 | 5.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.5 | 5.9 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 | 1.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.4 | 1.8 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 3.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.4 | 1.3 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.4 | 1.3 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.4 | 2.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.4 | 1.7 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.4 | 11.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.4 | 1.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.4 | 2.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.4 | 1.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 | 1.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 | 1.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 | 2.1 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.4 | 2.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.4 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.4 | 1.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.4 | 0.4 | GO:1990138 | neuron projection extension(GO:1990138) |
| 0.4 | 1.2 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.4 | 1.6 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.4 | 2.1 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 0.4 | 5.7 | GO:0035878 | nail development(GO:0035878) |
| 0.4 | 0.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.4 | 1.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.4 | 2.4 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.4 | 0.4 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
| 0.4 | 0.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.4 | 1.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.4 | 3.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.4 | 0.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.4 | 1.2 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 0.4 | 1.9 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.4 | 3.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.4 | 0.8 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.4 | 1.2 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.4 | 1.5 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.4 | 3.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.4 | 1.1 | GO:0048627 | myoblast development(GO:0048627) |
| 0.4 | 1.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.4 | 0.4 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.4 | 2.2 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.4 | 2.6 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.4 | 1.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.4 | 0.7 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.4 | 1.1 | GO:2000412 | activation of MAPK activity involved in innate immune response(GO:0035419) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 0.4 | 1.1 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.4 | 1.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.4 | 0.4 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.4 | 5.8 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.4 | 1.1 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.4 | 2.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.4 | 2.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.4 | 1.4 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.4 | 3.2 | GO:0015705 | iodide transport(GO:0015705) |
| 0.3 | 1.4 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.3 | 1.4 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 | 0.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.3 | 1.4 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.3 | 2.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.3 | 2.8 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.3 | 2.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.3 | 1.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.3 | 0.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.3 | 1.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 | 0.3 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.3 | 1.0 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.3 | 1.0 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.3 | 2.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 | 1.0 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.3 | 1.0 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.3 | 2.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.3 | 2.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.3 | 3.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 | 1.3 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.3 | 1.3 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.3 | 2.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.3 | 3.9 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.3 | 1.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 | 3.8 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.3 | 0.9 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 | 0.9 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.3 | 0.6 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.3 | 1.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.3 | 0.3 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.3 | 2.2 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.3 | 1.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 | 2.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 | 8.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.3 | 5.0 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.3 | 1.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.3 | 2.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.3 | 2.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 | 1.5 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.3 | 0.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.3 | 0.9 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.3 | 0.9 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.3 | 1.5 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.3 | 0.6 | GO:0000303 | response to superoxide(GO:0000303) |
| 0.3 | 0.6 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.3 | 3.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.3 | 1.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.3 | 1.5 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.3 | 1.2 | GO:1990834 | response to odorant(GO:1990834) |
| 0.3 | 1.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.3 | 0.6 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.3 | 1.2 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.3 | 1.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 | 1.5 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.3 | 4.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.3 | 1.5 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.3 | 1.8 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.3 | 0.6 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.3 | 7.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.3 | 1.5 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.3 | 1.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.3 | 0.3 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.3 | 1.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 | 1.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.3 | 1.2 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
| 0.3 | 0.9 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.3 | 1.2 | GO:0002545 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.3 | 4.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.3 | 0.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.3 | 2.6 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.3 | 3.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.3 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.3 | 1.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 | 1.1 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.3 | 0.9 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 | 0.9 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.3 | 0.6 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.3 | 0.6 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
| 0.3 | 0.9 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.3 | 1.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.3 | 1.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.3 | 0.8 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.3 | 1.4 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.3 | 0.6 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.3 | 1.1 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.3 | 2.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.3 | 1.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.3 | 1.1 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
| 0.3 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
| 0.3 | 0.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.3 | 1.4 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.3 | 0.8 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.3 | 1.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 | 1.1 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.3 | 4.4 | GO:0051608 | histamine transport(GO:0051608) |
| 0.3 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.3 | 3.0 | GO:0060022 | hard palate development(GO:0060022) |
| 0.3 | 1.1 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 | 3.3 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.3 | 1.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 0.8 | GO:0070482 | response to oxygen levels(GO:0070482) |
| 0.3 | 1.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 1.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.3 | 1.1 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.3 | 1.1 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.3 | 1.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.3 | 6.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.3 | 0.8 | GO:0050894 | determination of affect(GO:0050894) |
| 0.3 | 2.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.3 | 1.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.3 | 1.3 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 | 0.5 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.3 | 6.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.3 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.3 | 0.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.3 | 1.6 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.3 | 3.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.3 | 1.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 | 1.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.3 | 1.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.3 | 1.0 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.3 | 0.8 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.3 | 0.3 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 | 2.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.3 | 1.3 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.3 | 1.8 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.3 | 2.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 | 2.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.3 | 1.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.3 | 0.3 | GO:0051961 | negative regulation of nervous system development(GO:0051961) |
| 0.3 | 2.3 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.3 | 1.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.3 | 3.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.3 | 2.3 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 0.2 | 1.2 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.2 | 1.0 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 | 0.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.2 | 0.2 | GO:0032637 | interleukin-8 production(GO:0032637) |
| 0.2 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.2 | 0.7 | GO:2000145 | regulation of cell motility(GO:2000145) |
| 0.2 | 0.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.2 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.2 | 2.2 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 0.2 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.2 | 0.5 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.2 | 1.0 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
| 0.2 | 0.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
| 0.2 | 0.7 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.2 | 2.6 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 | 0.5 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 | 1.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.2 | 0.2 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.2 | 2.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 | 0.7 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.2 | 0.2 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 | 1.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 3.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 | 0.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.2 | 1.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.2 | 0.9 | GO:0072144 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.2 | 0.2 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.2 | 0.7 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.2 | 0.2 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 0.2 | 0.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 | 1.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 | 7.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.2 | 0.7 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.2 | 5.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.2 | 1.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 | 0.7 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.2 | 0.4 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.2 | 0.7 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.2 | 1.1 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.2 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.2 | 0.7 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.2 | 1.8 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.2 | 5.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 | 0.2 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.2 | 2.6 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.2 | 1.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 1.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.2 | 0.2 | GO:1901991 | negative regulation of cell cycle phase transition(GO:1901988) negative regulation of mitotic cell cycle phase transition(GO:1901991) |
| 0.2 | 1.1 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.2 | 0.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.2 | 0.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 0.2 | 1.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.2 | 0.9 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 0.9 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.2 | 0.4 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.2 | 3.6 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.2 | 2.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 | 0.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.2 | 0.4 | GO:1903206 | negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.2 | 0.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.2 | 0.8 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.2 | 1.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.2 | 0.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 | 2.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 | 0.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.2 | 0.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.2 | 0.6 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.2 | 0.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 | 0.4 | GO:0033121 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.2 | 0.8 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.2 | 0.8 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 | 1.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 0.2 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.2 | 0.6 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 1.0 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.2 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.2 | 3.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.2 | 0.6 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 | 2.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 | 3.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 | 0.6 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.2 | 1.6 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
| 0.2 | 1.4 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
| 0.2 | 0.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.2 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 0.2 | 1.4 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 | 2.0 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 1.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 | 1.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 0.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 | 0.6 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.2 | 1.0 | GO:0048749 | compound eye development(GO:0048749) |
| 0.2 | 0.6 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.2 | 4.1 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.2 | 0.6 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.2 | 1.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 | 0.6 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.2 | 4.1 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 1.2 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.2 | 0.8 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-k |